While GLP-1s are effective at suppressing appetite and reducing food intake in the short term, emerging research raises concerns about weight cyclingthe repeated loss and regain of weightwhich is both common and biologically driven after discontinuation
Research interest focuses on its ability to protect cellular components from oxidative damage caused by reactive oxygen species (ROS), heavy metals, and free radicals
There are clear opportunities for further research with MT1 to examine clinically significant endpoints, such as quality of life, reduced pain, and improved mood in patients afflicted by various skin and light-sensitivity conditions
With personalized care and ongoing monitoring, we help you safely switch to FDA-approved treatments, setting you up for long-term success in managing your weight
All PlexusDx semaglutide comes from licensed 503A compounding pharmacies and requires no insurance, making consistent treatment accessible for patients prioritizing cardiac protection
The up-titration window